SEC 13F Intelligence

Managers / Q1 2026

Aldebaran Capital, LLC

CIK 0001448430 · 10293 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46290 · 317-818-7827

Reported Value
$131M
Q1 2026
Positions
43
Filings on Record
14
2019–present window
Filed
May 7, 2026
original filing

Summary

Aldebaran Capital, LLC reported $131M in U.S.-listed holdings across 43 positions for Q1 2026.

Its largest position, BRK/B, represents 14.7% of the portfolio.

Compared with Q4 2025, the fund opened 8 new positions and exited 0.

Portfolio Metrics

Turnover
+4.6%
vs prior filed quarter
Top-10 Concentration
+62.7%
share of reported value
Largest Position
+14.7%
Berkshire Hathaway

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $97MQ4 ’22Q1 ’23: $98MQ2 ’23: $97MQ2 ’23Q3 ’23: $98MQ4 ’23: $98MQ4 ’23Q1 ’24: $105MQ2 ’24: $107MQ2 ’24Q3 ’24: $110MQ4 ’24: $105MQ4 ’24Q1 ’25: $106MQ2 ’25: $101MQ2 ’25Q3 ’25: $109MQ4 ’25: $112MQ4 ’25Q1 ’26: $131Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 80.0%Other: 8.2%ETP: 7.7%ADR: 3.9%Equity WRT: 0.2%
  • Common Stock · 80.0% · $105M
  • Other · 8.2% · $11M
  • ETP · 7.7% · $10M
  • ADR · 3.9% · $5M
  • Equity WRT · 0.2% · $306,220

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GLNCYGLENCORE PLCNEW+335.1K335.1K+$5M$5M
LKQ1LKQ CORPNEW+102.1K102.1K+$3M$3M
JXC1ZIFF DAVIS INCNEW+41.2K41.2K+$2M$2M
ISHARES TR MSCI JP VALUENEW+16.6K16.6K+$706,829$706,829
OCCIDENTAL PETE CORPNEW+7.1K7.1K+$306,220$306,220
BMOBANK MONTREAL QUENEW+1.7K1.7K+$230,078$230,078
EXMOCEXXON MOBIL CORPNEW+1.2K1.2K+$211,227$211,227
HURCHURCO CONEW+13.7K13.7K+$201,954$201,954

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

41 positions
#IssuerClass% PortfolioValueShares
1BRK/BBERKSHIRE HATHAWAY INC DELCL B NEW · COM15.82%$21M40.2K
2OXYOCCIDENTAL PETE CORPCOM · star W EXP 08/03/2027.89%$10M161.3K
3BUNGE LIMITEDCOM6.57%$9M67.6K
4LLYLILLY ELI & COhistory →COM6.33%$8M9.0K
5MSFTMICROSOFT CORPhistory →COM5.76%$8M20.4K
6SUSUNCOR ENERGY INC NEWhistory →COM5.23%$7M103.5K
7ISHARES TR RUS MDCP VALETF4.47%$6M40.1K
8CHVCHEVRON CORP NEWhistory →COM4.19%$5M26.5K
9GLNCYGLENCORE PLChistory →UNSP ADR3.89%$5M335.1K
10BACBANK AMERICA CORPhistory →COM3.88%$5M104.2K
11ACRSACLARIS THERAPEUTICS INChistory →COM2.72%$4M947.2K
12ABRDN ETFSBBRG ALL COMD K12.66%$3M143.4K
13CENXCENTURY ALUM COhistory →COM2.58%$3M57.6K
14CO2ACATO CORP NEWhistory →COM2.55%$3M1.18M
15JPMJPMORGAN CHASE & COhistory →COM2.54%$3M11.3K
16BACVERIZON COMMUNICATIONS INChistory →COM2.30%$3M59.9K
17LKQ1LKQ CORPhistory →COM2.29%$3M102.1K
18FCXFREEPORT-MCMORAN INChistory →COM2.19%$3M48.8K
19AMLXAMYLYX PHARMACEUTICALS INChistory →COM2.10%$3M197.9K
20SIRISIRIUS XM HOLDINGS INChistory →COMMON STOCK2.04%$3M115.4K
21ENBENBRIDGE INChistory →COM1.65%$2M39.9K
22JXC1ZIFF DAVIS INChistory →COM1.32%$2M41.2K
23MOHMOLINA HEALTHCARE INChistory →COM1.28%$2M12.6K
24PATKPATRICK INDS INChistory →COM1.18%$2M13.9K
25AN2 THEREAPEUTICS INCCOM0.97%$1M371.8K
26TECXTECTONIC THERAPEUTIC INCCOM0.88%$1M37.2K
27RELLRICHARDSON ELECTRS LTDCOM0.79%$1M94.0K
28ISHARES TR MSCI JP VALUEETF0.54%$706,82916.6K
292KZ0KEZAR LIFE SCIENCES INCCOM NEW0.46%$596,08680.3K
30PMVPPMV PHARMACEUTICALS INCCOM0.45%$586,969473.4K
31AVIRATEA PHARMACEUTICALS INCCOM0.37%$483,90989.9K
32DUKE ENERGY CORP NEWCOM NEW0.36%$471,3843.6K
33MBINMERCHANTS BANCORP INDCOM0.33%$434,46410.1K
34GENERAL ELECTRIC COCOM0.27%$354,9961.3K
35FFORD MTR CO DELCOM0.24%$317,35027.5K
36GEVGE VERNOVA INCCOM0.22%$289,803332
37BMOBANK MONTREAL QUECOM0.18%$230,0781.7K
38EXMOCEXXON MOBIL CORPCOM0.16%$211,2271.2K
39HURCHURCO COCOM0.15%$201,95413.7K
40OKURONKURE THERAPEUTICS INCCOM CL A0.13%$167,33540.4K
41IMAIMAGENEBIO INCCOM0.07%$92,83018.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$131M43May 7, 202613F-HRchanges · EDGAR ↗
Q4 2025$112M35Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$109M33Nov 10, 202513F-HRchanges · EDGAR ↗
Q2 2025$101M34Aug 12, 202513F-HRchanges · EDGAR ↗
Q1 2025$106M41May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$105M37Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$110M37Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$107M36Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$105M33May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$98M31Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$98M33Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$97M33Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$98M34May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022$97M34Feb 13, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.